stockrow
Friday 6 November 2026
Export MHUAF’s income statement to Excel — free account
Meihua International Medical Technologies Co., Ltd.
MHUAF Healthcare Medical Instruments & Supplies
Meihua International Medical Technologies Co., Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $61.8 million, down 36.2% from fiscal 2024.
6.00
0.86
−12.54%
Follow MHUAF
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | |||||||||||||||||
| Income, $m | Revenue | — | — | — | 80 | 89 | 104 | 103 | 97 | 97 | 62 | (4.1%) | — | — | — | — | |
| Gross margin, % | — | — | — | 40.10 | 41.72 | 38.26 | 36.86 | 34.19 | 34.36 | 31.01 | (9.1) pt | ||||||
| EBT | — | — | — | 19 | 24 | 26 | 11 | 15 | 14 | 9 | (11.3%) | ||||||
| EBT margin, % | — | — | — | 24.18 | 26.65 | 25.21 | 10.54 | 15.50 | 14.06 | 15.22 | (9.0) pt | ||||||
| Net income | — | 0 | — | 15 | 19 | 21 | 6 | 12 | 11 | 7 | n/m | ||||||
| Per share, $ | |||||||||||||||||
| Per share, $ | Revenue | — | — | — | 3.30 | 445.31 | 520.19 | 441.46 | 405.59 | 354.07 | 164.34 | +91.8% | |||||
| Earnings | — | — | — | 0.64 | 95.23 | 100.00 | 27.00 | 49.00 | 40.00 | 18.04 | +74.5% | ||||||
| Cash flow | — | — | — | 0.39 | 26.63 | (0.27) | (39.14) | 9.51 | 53.48 | 1.52 | +25.6% | ||||||
| Capex | — | — | — | 0.00 | (80.47) | (4.17) | (11.43) | (18.12) | (0.49) | (0.04) | n/m | ||||||
| Free cash flow | — | — | — | 0.39 | (53.84) | (4.44) | (50.57) | (8.62) | 52.99 | 1.47 | +25.0% | ||||||
| Book value | — | — | — | 2.47 | 423.68 | 538.84 | 592.39 | 613.36 | 580.84 | 502.48 | +142.5% | ||||||
| Shares, m | — | — | — | 24 | 0 | 0 | 0 | 0 | 0 | 0 | (50.0%) | ||||||
| Valuation, × | |||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | — | |||||
| P/S | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| P/B | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| EV/Sales | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| EV/FCF | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.51 | (0.79) | (0.88) | (0.2) | ||||||
| Cash, $m | |||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | 9 | 5 | 0 | (9) | 2 | 15 | 1 | (37.2%) | |||||
| Capex | — | — | — | (9) | (16) | (1) | (3) | (4) | 0 | 0 | (65.3%) | ||||||
| Free cash flow | — | — | — | 9 | (11) | (1) | (12) | (2) | 15 | 1 | (37.5%) | ||||||
| Balance, $m | |||||||||||||||||
| Balance, $m | Working capital | — | — | — | 39 | 46 | 68 | 111 | 107 | 116 | 135 | +23.0% | |||||
| Net debt | — | — | — | (13) | (4) | (3) | (20) | (10) | (9) | (6) | (12.2%) | ||||||
| Shareholders’ equity | — | — | — | 60 | 85 | 108 | 139 | 147 | 159 | 189 | +21.2% | ||||||
| Returns, % | |||||||||||||||||
| Returns, % | ROA | — | — | — | 42.16 | 21.25 | 17.25 | 4.16 | 6.93 | 6.06 | 3.45 | (38.7) pt | |||||
| ROIC | — | — | — | 0.00 | 18.16 | 15.66 | 5.68 | 6.68 | 5.98 | 2.83 | +2.8 pt | ||||||
| ROE | — | — | — | 21.37 | 26.38 | 21.77 | 5.07 | 8.14 | 7.09 | 3.90 | (17.5) pt | ||||||
| People | |||||||||||||||||
| People | Employees | — | — | — | — | 629 | 622 | 626 | 617 | 619 | 486 | (5.0%) | |||||
| Revenue/emp, $m | — | — | — | 0.00 | 0.14 | 0.17 | 0.17 | 0.16 | 0.16 | 0.13 | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · fundamentals updated 25 Oct 2026
Meihua International Medical Technologies Co., Ltd. vs peers in Medical Instruments & Supplies (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| MLSS Milestone Scientific, Inc. | $27.1M | — (loss-making) | — (loss-making) | +22.27% (above 0%: growing) | n/m | +66.68% (above 0%: growing) | 67.24% | (37.37%) | Compare |
| RVP Retractable Technologies, Inc. | $16.9M | — (loss-making) | 11.1× | −31.07% (below 0%: shrinking) | n/m | +56.67% (above 0%: growing) | 2.65% | (71.46%) | Compare |
| BNGO Bionano Genomics, Inc. | $15.4M | — (loss-making) | — (loss-making) | +21.36% (above 0%: growing) | n/m | −33.93% (below 0%: shrinking) | 52.80% | (88.34%) | Compare |
| NXGL NexGel, Inc. | $12.7M | — (loss-making) | — (loss-making) | +27.81% (above 0%: growing) | n/m | −432.32% (below 0%: shrinking) | 30.09% | (67.96%) | Compare |
| FEMY Femasys Inc. | $11.0M | — (loss-making) | — (loss-making) | −18.93% (below 0%: shrinking) | n/m | +11.29% (above 0%: growing) | 57.08% | (1,526.79%) | Compare |
| CUPR Cuprina Holdings (Cayman) Limited | $10.4M | — | — | — | — | — | — | — | Compare |
| RGNT Regentis Biomaterials Ltd. | $8.2M | — | — | — | — | −132.79% (below 0%: shrinking) | — | — | Compare |
| LUCY Innovative Eyewear, Inc. | $7.2M | — (loss-making) | — | +74.46% (above 0%: growing) | n/m | +9.61% (above 0%: growing) | 24.00% | (168.73%) | Compare |
| MHUAF Meihua International Medical Technologies Co., Ltd. | $4.3M | — | — | — | — | −61.55% (below 0%: shrinking) | 35.48% | 0.00% | |
| Median of peers | $11.8M | — | — | +21.82% | — | +9.61% | 41.45% | (79.90%) |